课题基金 / 基金详情

ATORVASTATIN FOR TREATMENT OF PCOS WOMEN WITH ELEVATED LDL CHOLESTEROL

ATORVASTATIN FOR TREATMENT OF PCOS WOMEN WITH ELEVATED LDL CHOLESTEROL
阿托伐他汀用于治疗 LDL 胆固醇升高的 PCOS 女性
批准号:
7951241
负责人:
RICHARD S. LEGRO
金额:
$0.65万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2010-03-31

项目摘要

项目成果

RICHARD S. LEGRO的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The overall hypothesis of this proposal is that abnormal lipid levels may play a more central role in the development of Polycystic Ovary Syndrome (PCOS), and therefore, interventions to normalize lipid levels may result in improved vascular function, as well as, improved hyperandrogenemia and insulin sensitivity which may lower the risk for cardiovascular disease in women with PCOS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Early Intervention to Promote Cardiovascular Health of Mothers and Children in Northern Appalachia
Early Intervention to Promote Cardiovascular Health of Mothers and Children in Northern Appalachia
Inositol Supplementation to Treat Reproductive and Metabolic Dysfunction in Polycystic Ovary Syndrome: A Double Blind RCT (INSUPP-PCOS)
Inositol Supplementation to Treat Reproductive and Metabolic Dysfunction in Polycystic Ovary Syndrome: A Double Blind RCT (INSUPP-PCOS)
海外基金